THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO...Warrant Agreement • January 4th, 2018 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 4th, 2018 Company Industry JurisdictionThis Certifies That, for value received, ____________________________ or its assigns (the “Holder”), is entitled to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation, with its principal office in Bethesda, Maryland (the “Company”), such number of Exercise Shares as provided herein at the Exercise Price as provided herein. This Class D-2 Warrant (the “Warrant”) is being issued pursuant to the terms of that certain Subscription Agreement, dated __________, 2017, by and among the Company and Holder (the “Agreement”).
NORTHWEST BIOTHERAPEUTICS, INC.Warrant Agreement • December 7th, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 7th, 2017 Company Industry JurisdictionThis Certifies That, for value received, ____________________________ or its assigns (the “Holder”), is entitled to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation, with its principal office in Bethesda, Maryland (the “Company”), such number of Exercise Shares as provided herein at the Exercise Price as provided herein. This Warrant is being issued pursuant to the terms of that certain Subscription Agreement, dated __________, 2017, by and among the Company and Holder (the “Agreement”).